{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T04:14:36Z","timestamp":1688357676386},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.9561","type":"journal-article","created":{"date-parts":[[2013,6,30]],"date-time":"2013-06-30T22:55:31Z","timestamp":1372632931000},"page":"1531-1536","source":"Crossref","is-referenced-by-count":2,"title":["Necrotizing Pneumonia due to Femoral Osteomyelitis Caused by Community-acquired Methicillin-resistant &lt;i&gt;Staphylococcus aureus&lt;\/i&gt;"],"prefix":"10.2169","volume":"52","author":[{"given":"Naoki","family":"Iwanaga","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"},{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"},{"name":"Department of Laboratory Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Soda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant <i>Staphylococcus aureus<\/i> at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 279: 441-448, 1968."},{"key":"2","unstructured":"2. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to <i>Staphylococcus species<\/i>: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 (Suppl 2): S114-S132, 2001."},{"key":"3","unstructured":"3. Centers for Disease Control. Community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i> infections-Michigan. MMWR Morb Mortal Wkyl Rep 30: 185-187, 1981."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i>. Clin Infect Dis 46: S368-S377, 2008.","DOI":"10.1086\/533593"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Prevalence of methicillin-resistant <i>staphylococcus aureus<\/i> as an etiology of community-acquired pneumonia. Clin Infect Dis 54: 1126-1133, 2012.","DOI":"10.1093\/cid\/cis022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant <i>Staphylococcus aureus<\/i> carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40: 100-107, 2005.","DOI":"10.1086\/427148"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44: S27-S72, 2007.","DOI":"10.1086\/511159"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wiersma P, D'Angelo T, Daley R, et al. Surveillance for severe community-associated MRSA infection. Epidemiol Infect 137: 1674-1678, 2009.","DOI":"10.1017\/S0950268809002490"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gillet Y, Issartel B, Vanhems P, et al. Association between <i>Staphylococcus aureus<\/i> strains carrying gene for PVL and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359: 753-759, 2002.","DOI":"10.1016\/S0140-6736(02)07877-7"},{"key":"10","unstructured":"10. Tomita Y, Kawano O, lchiyasu H, et al. Two cases of severe necrotizing pneumonia caused by community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i>. The Journal of the Japanese Respriratory Society 46: 395-403, 2008."},{"key":"11","unstructured":"11. Gando S, Iba T, Eguchi Y, et al. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34: 625-631, 2006."},{"key":"12","unstructured":"12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Fifteenth informational supplement. M-100-S15. Clinical and Laboratory Standards Institute, Wayne, PA, 2003."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Germel C, Haag A, S&ouml;derquist B. In vitro activity of beta-lactam antibiotics to community-associated methicillin-resistant <i>Staphylococcus aureus<\/i> (CA-MRSA). European journal of clinical microbiology &amp; infectious diseases: official publication of the European Society of Clinical Microbiology 31: 475-480, 2012.","DOI":"10.1007\/s10096-011-1333-8"},{"key":"14","unstructured":"14. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i>: an emerging threat. Lancet Infect Dis 5: 275-286, 2005."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wong KS, Lin TY, Huang YC, Hsia SH, Yang PH, Chu SM. Clinical and radiographic spectrum of septic pulmonary embolism. Arch Dis Child 87: 312-315, 2002.","DOI":"10.1136\/adc.87.4.312"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lin MY, Rezai K, Schwartz DN. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i>. J Clin Microbiol 46: 1553-1555, 2008.","DOI":"10.1128\/JCM.02379-07"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired <i>Staphylococcus aureus<\/i> infection. Clin Infect Dis 41: 583-590, 2005.","DOI":"10.1086\/432475"},{"key":"18","unstructured":"18. Minnesota Department of Health. Community-associated methicillin-resistant <i>Staphylococcus aureus<\/i> in Minnesota. Disease Control Newsletter. Minnesota Department of Health, 2004: 61-72."},{"key":"19","unstructured":"19. David M, Daum R. Community-associated methicillin-resistant <i>Staphylococcus aureus<\/i>: epidemiology and clinical consequences of an emerging epidemic. Clin Micro Rev 23: 616-687, 2010."},{"key":"20","unstructured":"20. Motoshima M, Yanagihara K, Morinaga Y, et al. Genetic diagnosis of community-acquired MRSA: a multiplex real-time PCR method for Staphylococcal cassette chromosome mec typing and detecting toxin genes. Tohoku J. Exp. Med 220: 165-170, 2010."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Moriyama H, Matsuda C, Shibata H, Nishimura N, Hirose M, Nagai A. Usefulness of phage ORF typing, a rapid genotyping method as a molecular and epidemiological method for detecting methicillin resistant <i>Staphylococcus aureus<\/i>. Kansenshogaku Zasshi 86: 115-120, 2012 (in Japanese, Abstract in English).","DOI":"10.11150\/kansenshogakuzasshi.86.115"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nada T, Yagi T, Ohkura T, et al. Usefulness of phage open-reading frame typing method in an epidemiological study of an outbreak of methicillin-resistant <i>Staphylococcus aureus<\/i> infections. Jpn J Infect Dis 62: 386-389, 2009.","DOI":"10.7883\/yoken.JJID.2009.386"},{"key":"23","unstructured":"23. Yanagihara K, Araki N, Watanabe S, et al. Antimicrobial susceptibility and molecular characteristics of 857 methicillin-resistant <i>Staphylococcus aureus<\/i> isolates from 16 medical centers in Japan (2008-2009): nationwide survey of community-acquired and nosocomial MRSA. Diagn Microbiol Infect Dis 72: 253-257, 2012."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Konig B, Prevost G, Piemon Y, et al. Effects of <i>Staphylococcus aureus<\/i> leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171: 607-613, 1995.","DOI":"10.1093\/infdis\/171.3.607"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by <i>Staphylococcus aureus<\/i> containing Panton-Valentine leukocidin. Clin Infect Dis 45: 315-321, 2007.","DOI":"10.1086\/519263"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Campo MR, Hachem Y, Jiang T, et al. Panton valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant <i>Staphylococcus aureus<\/i> (MRSA) infections. Medicine (Baltimore) 90: 312-318, 2011.","DOI":"10.1097\/MD.0b013e31822d8978"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lalani T, Federspiel JJ, Boucher HW, et al. Associations between the genotypes of <i>Staphylococcus aureus<\/i> bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 46: 2890-2896, 2008.","DOI":"10.1128\/JCM.00905-08"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tseng CW, Kyme P, Low J, et al. <i>Staphylococcus aureus<\/i> Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS ONE 4: e6387, 2009.","DOI":"10.1371\/journal.pone.0006387"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Labandeira RM, Couzon F, Boisset S, et al. <i>Staphylococcus aureus<\/i> Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315: 1130-1133, 2007.","DOI":"10.1126\/science.1137165"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant <i>Staphylococcus aureus<\/i> infection. JAMA 290: 2976-2984, 2003.","DOI":"10.1001\/jama.290.22.2976"},{"key":"31","unstructured":"31. Guidelines for the Management of Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections in the US Navy and Marine Corps. Navy Environmental Health Center, August 2006."},{"key":"32","unstructured":"32. Barton-Forbes M, Hawkes M, Moore D, et al. Guidelines for the prevention and management of community associated methicillin resistant <i>Staphylococcus aureus<\/i> (CA-MRSA): a perspective for Canadian health care practitioners. Can. J Infect Dis Med Microbiol 17 (Suppl. C): 1B-24B, 2006."},{"key":"33","unstructured":"33. Scott TM, Michael D, Marin HK. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant <i>Staphylococcus aureus<\/i>: Importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128: 2732-2738, 2005."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wargo K, Eliand E. Appropriate antimicrobial therapy for community-acquired MRSA carrying the PVL genes. Clin Infect Dis 40: 1376-1378, 2005.","DOI":"10.1086\/429509"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. George KS, Tsigereda T, Karen C, James D. Failure of clindamycin treatment of methicillin-resistant <i>Staphylococcus aureus<\/i> expressing inducible clindamycin resistance in vitro. Clin Infect Dis 37: 1257-1260, 2003.","DOI":"10.1086\/377501"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/13\/52_52.9561\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:22:03Z","timestamp":1688325723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/13\/52_52.9561\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.9561","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}